A prestigious postdoctoral fellowship supporting innovative immuno-oncology research. The CRI Irvington Fellowship provides 3 years of funding for young scientists to train under the guidance of world-renowned immunologists or tumor immunology experts . Research areas include tumor immunology, immunotherapy mechanisms, vaccine science, and other cancer immunology topics. This fellowship enables promising researchers to deepen their expertise and generate data that can launch independent research careers in cancer immunology.
Eligibility Criteria:
-
Postdoctoral fellows working in immunology or cancer immunology labs, who have a doctoral degree (PhD, MD, or equivalent).
-
Must have less than 5 years of relevant postdoctoral experience at the time of award (early postdoc stage preferred).
-
Proposal should be cancer-focused and immunology-based (e.g., checkpoint blockade, CAR-T, tumor microenvironment, etc.).
-
No citizenship restrictions: international applicants are welcome, but research must be conducted at a non-profit institution (any country).
Funding Details:
-
$175,000 over 3 years, disbursed as annual stipends: $$ (rising each year, e.g., $74,000 Year 1, $76,000 Year 2, $78,000 Year 3).
-
Plus annual $5,000 institutional allowance to cover health insurance or research supplies.
-
No indirect costs; funds are for fellow’s salary and fringe benefits, with any remainder for lab expenses.
-
Fellows attend CRI’s annual International Cancer Immunotherapy Conference (registration/travel funded separately) and join CRI’s network of immuno-oncology researchers.
Deadline:
-
March 2, 2026: Application deadline for the Spring 2026 cycle (if March 1 falls on a weekend, deadline moves to next business day).
-
Notification by May 2026; funding begins July 1, 2026 (fellows can start later in 2026 if needed).
-
Second annual deadline in early September 2026 for the fall cycle (in case candidates miss spring round).
Where to go for further information:
- Program details.
- Contact: grants@cancerresearch.org.